India · Delayed Price · Currency is INR Brawn Biotech Statistics
Total Valuation
Brawn Biotech has a market cap or net worth of INR 63.91 million. The enterprise value is 61.10 million.
| Market Cap | 63.91M |
| Enterprise Value | 61.10M |
Important Dates
The last earnings date was Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Brawn Biotech has 3.00 million shares outstanding. The number of shares has decreased by -1.33% in one year.
| Current Share Class | 3.00M |
| Shares Outstanding | 3.00M |
| Shares Change (YoY) | -1.33% |
| Shares Change (QoQ) | -0.75% |
| Owned by Insiders (%) | 52.63% |
| Owned by Institutions (%) | n/a |
| Float | 920,741 |
Valuation Ratios
The trailing PE ratio is 7.35.
| PE Ratio | 7.35 |
| Forward PE | n/a |
| PS Ratio | 0.37 |
| PB Ratio | 1.47 |
| P/TBV Ratio | 1.47 |
| P/FCF Ratio | 74.64 |
| P/OCF Ratio | 57.13 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 7.11 |
| EV / Sales | 0.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 71.36 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -120.48 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -13.06% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.09% |
| Revenue Per Employee | 19.23M |
| Profits Per Employee | 954,444 |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -9.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.27% in the last 52 weeks. The beta is 0.15, so Brawn Biotech's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | +18.27% |
| 50-Day Moving Average | 20.98 |
| 200-Day Moving Average | 20.91 |
| Relative Strength Index (RSI) | 51.71 |
| Average Volume (20 Days) | 667 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Brawn Biotech had revenue of INR 173.07 million and earned 8.59 million in profits. Earnings per share was 2.90.
| Revenue | 173.07M |
| Gross Profit | 25.60M |
| Operating Income | -5.30M |
| Pretax Income | -805,000 |
| Net Income | 8.59M |
| EBITDA | -4.06M |
| EBIT | -5.30M |
| Earnings Per Share (EPS) | 2.90 |
Balance Sheet
The company has 2.81 million in cash and no debt, with a net cash position of 2.81 million or 0.94 per share.
| Cash & Cash Equivalents | 2.81M |
| Total Debt | n/a |
| Net Cash | 2.81M |
| Net Cash Per Share | 0.94 |
| Equity (Book Value) | 43.39M |
| Book Value Per Share | 14.50 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 1.12 million and capital expenditures -262,340, giving a free cash flow of 856,230.
| Operating Cash Flow | 1.12M |
| Capital Expenditures | -262,340 |
| Depreciation & Amortization | 1.24M |
| Net Borrowing | n/a |
| Free Cash Flow | 856,230 |
| FCF Per Share | 0.29 |
Margins
Gross margin is 14.79%, with operating and profit margins of -3.06% and 4.96%.
| Gross Margin | 14.79% |
| Operating Margin | -3.06% |
| Pretax Margin | -0.47% |
| Profit Margin | 4.96% |
| EBITDA Margin | -2.35% |
| EBIT Margin | -3.06% |
| FCF Margin | 0.50% |
Dividends & Yields
Brawn Biotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.33% |
| Shareholder Yield | 1.33% |
| Earnings Yield | 13.44% |
| FCF Yield | 1.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |